InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,716.00
(
0.43%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.20
(
0.29%
)
Bitcoin
62,970.28
(
-0.12%
)
Post# of 424141
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Pharmacydude

Send PM Follow Ignore
Followers 45
Posts 1512
Boards Moderated 0
Alias Born 11/25/2013

Pharmacydude

Re: ralphey post# 333387

Tuesday, 04/06/2021 3:44:24 PM

Tuesday, April 06, 2021 3:44:24 PM

Post# of 424141
Ralphey
I don’t see much use for the Avandia/Vascepa patent. Like you said,contra-indicated in pts with heart failure. Rarely see it prescribed. Too many newer, better options available these days. It’s a dead drug
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Start posting your company's news
Only $200 per official company press release!